Shares of Doximity, Inc. (DOCS), a leading digital platform for medical professionals, surged 5.14% on Friday, November 11, 2024, as multiple Wall Street analysts raised their price targets on the stock, citing the company's robust financial performance and strategic progress.

Doximity, which provides cloud-based software solutions and services to healthcare professionals, has been rapidly gaining traction in the healthcare technology sector. The company's strong revenue growth, expanding product offerings, and strategic initiatives have impressed analysts, leading them to raise their expectations for the stock.

Barclays analyst Vikram Kesavabhotla raised the firm's price target on Doximity to $75 from $52, maintaining an "Overweight" rating. Kesavabhotla cited the company's impressive third-quarter results and continued momentum in its core business as reasons for the increased price target. Other analysts, including those from Leerink Partners and Wolfe Research, also raised their price targets, highlighting Doximity's strong execution and promising growth prospects.